Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8951
FT Vest US Equity Deep Buffer ETF September
DSEP
$379M
| $384K | ﹤0.01% |
13,067
-12,586
| -49% | -$384K |
2021 Q2
5 quarters
|
|
8952
ProShares MSCI Europe Dividend Growers ETF
EUDV
$7.93M
| $384K | ﹤0.01% |
10,980
-780
| -7% | -$30.9K |
2022 Q2
1 quarter
|
|
8953
PUT
ImmunityBio
IBRX
$9.84B
| $384K | ﹤0.01% |
77,300
+5,200
| +7% | +$23.7K |
2020 Q2
9 quarters
|
|
8954
National Healthcare
NHC
$3.5B
| $384K | ﹤0.01% |
6,066
-5,493
| -48% | -$382K |
2022 Q2
1 quarter
|
|
8955
Norfolk Southern
NSC
$69.7B
| $384K | ﹤0.01% |
1,829
-376,605
| -100% | -$90.6M |
2021 Q1
6 quarters
|
|
8956
Invesco S&P 500 Quality ETF
SPHQ
$18.8B
| $384K | ﹤0.01% |
9,664
-34,997
| -78% | -$1.54M |
2022 Q2
1 quarter
|
|
8957
Willdan Group
WLDN
$1.13B
| $384K | ﹤0.01% |
25,946
+17,089
| +193% | +$409K |
2021 Q1
6 quarters
|
|
|
ZUO
8958
PUT
DELISTED
Zuora, Inc.
ZUO
| $384K | ﹤0.01% |
52,000
-45,000
| -46% | -$388K |
2018 Q2
17 quarters
|
|
8959
CALL
Acadia Healthcare
ACHC
$2.51B
| $383K | ﹤0.01% |
4,900
-100
| -2% | -$7.99K |
2020 Q2
9 quarters
|
|
|
ARR
8960
PUT
Armour Residential REIT
ARR
$1.95B
| $383K | ﹤0.01% |
15,740
+5,780
| +58% | +$203K |
2017 Q2
21 quarters
|
|
8961
CALL
Blackbaud
BLKB
$1.93B
| $383K | ﹤0.01% |
8,700
-60,300
| -87% | -$3.25M |
2020 Q4
7 quarters
|
|
8962
PUT
Capital Southwest
CSWC
$1.48B
| $383K | ﹤0.01% |
22,600
+4,100
| +22% | +$79K |
2021 Q1
6 quarters
|
|
|
ESPR
8963
PUT
DELISTED
Esperion Therapeutics
ESPR
| $383K | ﹤0.01% |
57,200
+19,000
| +50% | +$130K |
2016 Q4
23 quarters
|
|
|
NXDR
8964
Nextdoor Holdings
NXDR
$959M
| $383K | ﹤0.01% |
+137,430
| New | +$453K |
2022 Q3
0 quarters
|
|
8965
PUT
Primerica
PRI
$8.46B
| $383K | ﹤0.01% |
+3,100
| New | +$393K |
2022 Q3
0 quarters
|
|
8966
Rackspace Technology
RXT
$984M
| $383K | ﹤0.01% |
+93,759
| New | +$544K |
2022 Q3
0 quarters
|
|
|
SFYX
8967
DELISTED
SoFi Next 500 ETF
SFYX
| $383K | ﹤0.01% |
37,064
| – | – |
2022 Q1
2 quarters
|
|
|
SPTN
8968
CALL
DELISTED
SpartanNash
SPTN
| $383K | ﹤0.01% |
13,200
-500
| -4% | -$15.5K |
2020 Q1
10 quarters
|
|
8969
PUT
USA Compression Partners
USAC
$3.66B
| $383K | ﹤0.01% |
22,000
-5,900
| -21% | -$104K |
2019 Q4
11 quarters
|
|
8970
Virtus Reaves Utilities ETF
UTES
$1.14B
| $383K | ﹤0.01% |
8,885
-4,212
| -32% | -$202K |
2022 Q2
1 quarter
|
|
|
SILK
8971
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $383K | ﹤0.01% |
8,510
-22,740
| -73% | -$978K |
2020 Q4
7 quarters
|
|
8972
CALL
Aldeyra Therapeutics
ALDX
$77.8M
| $382K | ﹤0.01% |
+71,500
| New | +$429K |
2022 Q3
0 quarters
|
|
8973
PUT
iShares MSCI ACWI ETF
ACWI
$32.8B
| $381K | ﹤0.01% |
4,900
-200
| -4% | -$17.3K |
2017 Q2
21 quarters
|
|
8974
Bank of Montreal
BMO
$116B
| $381K | ﹤0.01% |
4,347
-111,119
| -96% | -$10.7M |
2016 Q3
24 quarters
|
|
8975
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.38B
| $381K | ﹤0.01% |
+7,076
| New | +$416K |
2022 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.